Solakoglu Önder, Götz Werner, Kiessling Maren C, Alt Christopher, Schmitz Christoph, Alt Eckhard U
External Visiting Lecturer, Dental Department of the University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Department of Orthodontics, Center of Dento-Maxillo-Facial Medicine, University of Bonn, Bonn 53111, Germany.
World J Stem Cells. 2019 Feb 26;11(2):124-146. doi: 10.4252/wjsc.v11.i2.124.
Novel strategies are needed for improving guided bone regeneration (GBR) in oral surgery prior to implant placement, particularly in maxillary sinus augmentation (GBR-MSA) and in lateral alveolar ridge augmentation (LRA). This study tested the hypothesis that the combination of freshly isolated, unmodified autologous adipose-derived regenerative cells (UA-ADRCs), fraction 2 of plasma rich in growth factors (PRGF-2) and an osteoinductive scaffold (OIS) (UA-ADRC/PRGF-2/OIS) is superior to the combination of PRGF-2 and the same OIS alone (PRGF-2/OIS) in GBR-MSA/LRA.
A 79-year-old patient was treated with a bilateral external sinus lift procedure as well as a bilateral lateral alveolar ridge augmentation. GBR-MSA/LRA was performed with UA-ADRC/PRGF-2/OIS on the right side, and with PRGF-2/OIS on the left side. Biopsies were collected at 6 wk and 34 wk after GBR-MSA/LRA. At the latter time point implants were placed. Radiographs (32 mo follow-up time) demonstrated excellent bone healing. No radiological or histological signs of inflammation were observed. Detailed histologic, histomorphometric, and immunohistochemical analysis of the biopsies evidenced that UA-ADRC/PRGF-2/OIS resulted in better and faster bone regeneration than PRGF-2/OIS.
GBR-MSA with UA-ADRCs, PRGF-2, and an OIS shows effectiveness without adverse effects.
在种植体植入前的口腔外科手术中,尤其是在上颌窦提升术(GBR-MSA)和外侧牙槽嵴增高术(LRA)中,需要新的策略来改善引导骨再生(GBR)。本研究检验了以下假设:在GBR-MSA/LRA中,新鲜分离、未修饰的自体脂肪来源再生细胞(UA-ADRCs)、富含生长因子的血浆2组分(PRGF-2)和骨诱导支架(OIS)的组合(UA-ADRC/PRGF-2/OIS)优于单独的PRGF-2和相同的OIS组合(PRGF-2/OIS)。
一名79岁患者接受了双侧外提升术以及双侧外侧牙槽嵴增高术。右侧采用UA-ADRC/PRGF-2/OIS进行GBR-MSA/LRA,左侧采用PRGF-2/OIS。在GBR-MSA/LRA后6周和34周采集活检样本。在后者这个时间点植入种植体。X线片(随访32个月)显示骨愈合良好。未观察到炎症的放射学或组织学迹象。对活检样本进行的详细组织学、组织形态计量学和免疫组织化学分析证明,UA-ADRC/PRGF-2/OIS比PRGF-2/OIS能带来更好、更快的骨再生。
GBR-MSA联合UA-ADRCs、PRGF-2和OIS显示出有效性且无不良反应。